Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 12

1.

MicroRNA expression in cytogenetically normal acute myeloid leukemia.

Marcucci G, Radmacher MD, Maharry K, Mrózek K, Ruppert AS, Paschka P, Vukosavljevic T, Whitman SP, Baldus CD, Langer C, Liu CG, Carroll AJ, Powell BL, Garzon R, Croce CM, Kolitz JE, Caligiuri MA, Larson RA, Bloomfield CD.

N Engl J Med. 2008 May 1;358(18):1919-28. doi: 10.1056/NEJMoa074256.

2.

Prognostic significance of FLT3 internal tandem duplication, nucleophosmin 1, and CEBPA gene mutations for acute myeloid leukemia patients with normal karyotype and younger than 60 years: a systematic review and meta-analysis.

Port M, Böttcher M, Thol F, Ganser A, Schlenk R, Wasem J, Neumann A, Pouryamout L.

Ann Hematol. 2014 Aug;93(8):1279-86. doi: 10.1007/s00277-014-2072-6. Review.

PMID:
24801015
3.

Hematopoietic transplantation for acute myeloid leukemia with internal tandem duplication of FLT3 gene (FLT3/ITD).

Brunet S, Martino R, Sierra J.

Curr Opin Oncol. 2013 Mar;25(2):195-204. doi: 10.1097/CCO.0b013e32835ec91f. Review.

PMID:
23385863
4.

Prognostically important molecular markers in cytogenetically normal acute myeloid leukemia.

Lin TL, Smith BD.

Am J Med Sci. 2011 May;341(5):404-8. doi: 10.1097/MAJ.0b013e318201109d. Review.

5.

Molecular prognostic factors in cytogenetically normal acute myeloid leukemia.

Walker A, Marcucci G.

Expert Rev Hematol. 2012 Oct;5(5):547-58. doi: 10.1586/ehm.12.45. Review.

6.

MicroRNA expression in acute myeloid leukemia.

Marcucci G, Radmacher MD, Mrózek K, Bloomfield CD.

Curr Hematol Malig Rep. 2009 Apr;4(2):83-8. doi: 10.1007/s11899-009-0012-7. Review.

PMID:
20425419
7.

The prognostic and functional role of microRNAs in acute myeloid leukemia.

Marcucci G, Mrózek K, Radmacher MD, Garzon R, Bloomfield CD.

Blood. 2011 Jan 27;117(4):1121-9. doi: 10.1182/blood-2010-09-191312. Review.

8.

Molecular signatures in acute myeloid leukemia.

Mrózek K, Radmacher MD, Bloomfield CD, Marcucci G.

Curr Opin Hematol. 2009 Mar;16(2):64-9. doi: 10.1097/MOH.0b013e3283257b42. Review.

9.

MicroRNA expression profiling in acute myeloid and chronic lymphocytic leukaemias.

Marcucci G, Mrózek K, Radmacher MD, Bloomfield CD, Croce CM.

Best Pract Res Clin Haematol. 2009 Jun;22(2):239-48. doi: 10.1016/j.beha.2009.05.003. Review.

PMID:
19698931
10.

Acute myeloid leukemia: the challenge of capturing disease variety.

Löwenberg B.

Hematology Am Soc Hematol Educ Program. 2008:1-11. doi: 10.1182/asheducation-2008.1.1. Review.

PMID:
19074046
11.

microRNAs in acute myeloid leukemia: expression patterns, correlations with genetic and clinical parameters, and prognostic significance.

Wieser R, Scheideler M, Hackl H, Engelmann M, Schneckenleithner C, Hiden K, Papak C, Trajanoski Z, Sill H, Fonatsch C.

Genes Chromosomes Cancer. 2010 Mar;49(3):193-203. doi: 10.1002/gcc.20740. Review.

PMID:
20013895
12.

A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects.

Wouters BJ, Löwenberg B, Delwel R.

Blood. 2009 Jan 8;113(2):291-8. doi: 10.1182/blood-2008-04-153239. Review.

Items per page

Supplemental Content

Support Center